Astragaloside IV Inhibits the Proliferation of Human Uterine Leiomyomas by Targeting IDO1

SIMPLE SUMMARY: Immunotherapy is increasingly becoming a success strategy for oncology treatment. Indoleamine-2,3-dioxygenase1 (IDO1) is a tryptophan-degrading enzyme involved in immunological escape mechanisms, which is considered as a potential target for tumor therapy. However, the clinical effic...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiu, Tiantian, Li, Donghua, Liu, Yu, Ren, Hui, Yang, Xuan, Luo, Wenting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496999/
https://www.ncbi.nlm.nih.gov/pubmed/36139584
http://dx.doi.org/10.3390/cancers14184424

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496999/
https://www.ncbi.nlm.nih.gov/pubmed/36139584
http://dx.doi.org/10.3390/cancers14184424

Ejemplares similares